İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter medical ab* - sodium chloride - innrennslislyf, lausn - 9 mg/ml

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

fresenius kabi ab - alaninum inn; argininum inn; glycine; histidinum inn; isoleucinum inn; leucinum inn; lysinum asetat; methioninum inn; phenylalaninum inn; prolinum inn; serinum inn; taurinum inn; threoninum inn; tryptophanum inn; tyrosinum inn; valinum inn; calcii chloridum dihydricum inn; natrii glycerophosphas; magnesium sulfate heptahydrate; kalii chloridum; natrii acetas; zinc sulphate heptahydrate; glucose monohydrate; soiae oleum raffinatum; triglycerides medium chain; olivae oleum raffinatum; fish oil rich in omega-3 acids - innrennslislyf, fleyti

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

bluefish pharmaceuticals ab - escitalopramum oxalat - filmuhúðuð tafla - 10 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

bluefish pharmaceuticals ab - escitalopramum oxalat - filmuhúðuð tafla - 15 mg

Avrupa Birliği - İzlandaca - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - avatrombopag maleate - blóðflagnafæð - antihemorrhagics - doptelet er ætlað fyrir meðferð alvarlega blóðflagnafæð í fullorðinn sjúklinga með langvarandi lifrarsjúkdóm sem eru áætlað er að gangast undir innrásar aðferð. doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. barkstera, immúnóglóbúlín).

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

fresenius kabi ab - soya-bean oil refined; glucosum; alaninum inn; arginine; aspartic acid; glutamic acid; glycine; histidinum inn; isoleucinum inn; leucinum inn; lysinum inn; methioninum inn; phenylalaninum inn; proline; serine; threoninum inn; tryptophanum inn; tyrosinum inn; valine; natrii glycerophosphas; magnesii sulfas; kalii chloridum; sodium acetate trihydrate; calcium chloride dihydrate - innrennslislyf, fleyti

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter medical ab* - glucosum - innrennslislyf, lausn - 100 mg/ml

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

eisai ab - rabeprazolum natríum - magasýruþolin tafla - 10 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

eisai ab - rabeprazolum natríum - magasýruþolin tafla - 20 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter medical ab* - sodium chloride; kalii chloridum; magnesii chloridum; sodium acetate trihydrate; natrii gluconas - innrennslislyf, lausn